Tissue-specific and tissue-agnostic effects of genome sequence variation modulating blood pressure

Cell Rep. 2023 Nov 28;42(11):113351. doi: 10.1016/j.celrep.2023.113351. Epub 2023 Nov 1.

Abstract

Genome-wide association studies (GWASs) have identified numerous variants associated with polygenic traits and diseases. However, with few exceptions, a mechanistic understanding of which variants affect which genes in which tissues to modulate trait variation is lacking. Here, we present genomic analyses to explain trait heritability of blood pressure (BP) through the genetics of transcriptional regulation using GWASs, multiomics data from different tissues, and machine learning approaches. Approximately 500,000 predicted regulatory variants across four tissues explain 33.4% of variant heritability: 2.5%, 5.3%, 7.7%, and 11.8% for kidney-, adrenal-, heart-, and artery-specific variants, respectively. Variation in the enhancers involved shows greater tissue specificity than in the genes they regulate, suggesting that gene regulatory networks perturbed by enhancer variants in a tissue relevant to a phenotype are the major source of interindividual variation in BP. Thus, our study provides an approach to scan human tissue and cell types for their physiological contribution to any trait.

Keywords: CP: Genomics; blood pressure; complex traits; heritability; regulatory variants; transcriptional machinery.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Blood Pressure / genetics
  • Gene Expression Regulation
  • Gene Regulatory Networks
  • Genetic Variation
  • Genome-Wide Association Study*
  • Humans
  • Phenotype
  • Polymorphism, Single Nucleotide / genetics
  • Quantitative Trait Loci* / genetics